regeneron vice president salary

Prior to joining Regeneron, Dr. Baras contributed to other biotechnology ventures and conducted research spanning antibody-based therapeutics, cancer research and nanotechnology applications in drug development. #bestplacetowork #careers, The average Regeneron salary ranges from approximately $52,103 per year for, Regeneron employees attributed a compensation and benefits rating of 4.2/5 stars to their company. Previously, he held roles and responsibilities at Regeneron across R&D and business development. Average salary for PDR Network Vice President Business Development in West Point, PA: [salary]. from Northwestern University. He received his MBA from Northwestern University Kellogg School of Management. He received his Ph.D. in biochemistry from the University of Delaware and his MBA from the State University of New York at Albany. | Regeneron's CEO, Leonard Schleifer, M.D., Ph.D., collected a . Gilead Of this total $560,000 was received as a salary, $524,160 was received as a bonus, $7,875,030 was received in stock options, $0 was awarded as stock and $19,410 came from other types of compensation. Before joining Regeneron, he was at Progenics Pharmaceuticals for 19 years. from Hibernia College. The total cash compensation, which includes bonus, and annual incentives, can vary anywhere from $271,190 to $333,590 with the average total cash compensation of $295,590. from Harvard Medical School. Senior Vice President, IT and Chief Information Officer. The estimated total pay for a Vice President Operations at Regeneron is $448,608 per year. He trained in internal medicine at Harvard Medical Schools Brigham Hospital and Bostons University Hospital. This recognition is possible thanks to our dedicated colleagues, cutting-edge work and a culture that promotes limitless possibilities. Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. Average salaries for Regeneron Vice President Operations: [salary]. He leads the development of our next-generation genetic therapeutics platforms and is the head of the infectious diseases therapeutic focus area. The lowest-paying job at Regeneron is a Research Assistant with a salary of $52,103 per year. and M.D. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives. Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Prior to BOL, he spent 12 years at AstraZeneca/MedImmune in roles of increasing responsibility, ultimately building and overseeing the cardiovascular renal and metabolism clinical therapeutic area at MedImmune. Previously, he worked at Pfizer for 10 years focusing on research and early development of biologics, and before that he worked at Rinat Neuroscience Corporation after completing his postdoctoral fellowship at Genentech. Prior to joining Regeneron, Ms. Ravetti spent 10 years at Pfizer in various positions of increasing responsibility, and she was previously an Associate at the law firm of Sullivan and Cromwell. in biology from the State University of New York at Binghamton and an M.S. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. Aydanos a proteger Glassdoor y demustranos que eres una persona real. Ms. Lozner earned a B.S. Senior Vice President, Translational and Clinical Sciences, Oncology. Average salary for IPSEN Vice President Human Resources in Wherstead, England: [salary]. Dr. Tessier-Lavigne is also a member of the board of directors of Denali Therapeutics Inc. President Emeritus of Memorial SloanKettering Cancer Center. In 2020, Ms. Bermingham stepped forward to also serve as the companys interim head of diversity, equity and inclusion (DE&I). Scribe Therapeutics - Alameda On Fishbowl, you can share insights and advice anonymously with Regeneron employees and get real answers from people on the inside. Salary Range (annually) $75,700.00 - $123,500.00 R17524 Seniority level Mid-Senior level Employment type Full-time Job function Research, Analyst, and Information Technology Industries. Our leadership team possesses deep and diverse industry knowledge, a passion for science and a shared commitment to help transform lives. REGENERON PHARMACEUTICALS, INC. annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Salary.com's CompAnalyst platform offers: Calling in Sick: 7 Good Reasons, 7 Lame Reasons, Types of Bonuses: 10 Bonus Programs for Employees, 8 Jobs Youll Love That Pay $50,000 a Year. from the University of Wisconsin-Madison and his Ph.D. from the University of Washington. Johnathan M. Lancaster, M.D., Ph.D., joined Regeneron in 2019 as a vice president and now serves as SVP and head of global medical affairs. Before that, she has led global marketing research, corporate strategy and DE&I efforts at Fortune 50 companies such as Prudential Financial, Johnson & Johnson and ACNielsen. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex,. John Lin, M.D., Ph.D., joined Regeneron in 2016 and oversees the preclinical bispecific antibody research work in research and development across all disease areas. John Calabro joined Regeneron in 2005 and serves as senior vice president, internal audit. from the University of Buenos Aires. You may also find the annual proxy statement by going directly to the company's website. Mr. Fenimore holds an M.A. You are now leaving Regeneron.com to visit another Regeneron website. He received his Ph.D. in medicine and molecular biology from Kings College, University of Cambridge and his M.D. Marion McCourt joined Regeneron in 2018 and serves as executive vice president and head of the commercial organization. She started her career at Regeneron as a research engineer working in the purification development group within PMPD and has subsequently held roles of increasing responsibility. Smita Pillai joined Regeneron as our first chief diversity, equity and inclusion (DEI) officer in 2021. Based on 12 salaries posted anonymously by AstraZeneca Vice President Finance employees in Burton Latimer, England. He previously held roles in process development and preclinical manufacturing, clinical manufacturing and manufacturing sciences. How much do Regeneron employees make? , Dr. Baras received his B.S., MBA and M.D. Regeneron Dr. Schleifer, together with Regenerons founding scientist, Dr. Yancopoulos, built and managed the company over the past 35 years. He was also a professor at Stanford University from 2001 to 2003 and at the University of California, San Francisco from 1991 to 2001. Als u dit bericht blijft zien, stuur dan een e-mail Dr. Murphy is a co-inventor of several of Regeneron's key technologies, VelociGene and VelocImmune, and continues to lead several technology centers and therapeutic focus areas. degrees from Dartmouth. Mr. Drosman earned a B.S. Mr. Volpe received an A.S. in accounting from Suffolk County Community College, followed by a B.A. Of this total $822,800 was received as a salary, $1,052,182 was received as a bonus, $3,839,805 was received in stock options, $2,559,468 was awarded as stock and $24,200 came from other types of compensation. . Dr. Goldstein is a member of the National Academy of Sciences, the National Academy of Medicine and the Royal Society of London. Pfizer Dr. Bassler has previously served as the president of the American Society for Microbiology, as well as on the boards for the American Association for the Advancement of Science, the National Science Foundation and the American Academy of Microbiology. Dr. Schleifer is a licensed physician and is certified in neurology by the American Board of Psychiatry and Neurology. Senior Vice President, Translational and Clinical Sciences, Hematology. Senior Vice President, Clinical Development, Immunology and Inflammation. Compensation data tools, salary structures, surveys and benchmarks. As Executive Vice President and General Manager, Industrial Operations and Product Supply at REGENERON PHARMACEUTICALS, INC., Daniel Van Plew made $8,978,600 in total compensation. Regeneron's people make us who we are, and we are truly more than a company - we're a community. President, Chief Executive Officer and Chairman of the Board, Cerevel Therapeutics Holdings, Inc. Dr. Coles has been a director of the company since 2017. Dr. Goldstein has been a director of the company since 1991. The estimated base pay is $208,589 per year. Lori Morton, Ph.D., joined Regeneron in 2002 and serves as senior vice president, research. Ms. Lozner oversees all aspects of Regenerons corporate compliance program. from Siena College and his MBA from State University of New York at Albany. Prior to joining Johnson & Johnson, Ms. Poon held senior leadership positions at Bristol-Myers Squibb Company, including president of international medicines and president of medical devices. As on 2021. Chair in Business at the Max M. Fisher College of Business at The Ohio State University. CA. Boyce F. Martin, Jr., Chief Judge Emeritus, U.S. Court of Appeals for the Sixth Circuit. Gerald Underwood joined Regeneron in 1995 and serves as senior vice president, technical operations for the global industrial operations & product supply organization. Retired Chairman of the Board and Chief Executive Officer, Prudential Financial, Inc. Mr. Ryan has been a director of the company since 2003. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Prior to joining Regeneron, Mr. Yocum worked within the Chemistry Department at Seattle Pacific University. ABOUT COMMUNITY ACTION MARIN: Community Action Marin (CAM)'s mission is to promote members of Marin County to Berrett-Koehler Publishers - Oakland verdade. Senior Vice President, Global Patient Safety. and BBA in finance and economics abroad and his MBA at Temple University. Dr. Macdonald is responsible for heading the VelocImmune-NEXT technology development group, neuroscience group, molecular profiling & data sciences group, and DNA core & Aautomation group. Compensation data tools, salary structures, surveys and benchmarks. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. , The average salary for Vice President of Information Technology at companies like REGENERON PHARMACEUTICALS, INC. in the United States is $426,507 as of April 26, 2022, but the salary range typically falls between $354,139 and $516,809. Please enable Cookies and reload the page. from the University of Pennsylvania and his B.A. in biochemistry and cell biology from the University of California, San Diego, and his M.D. Neil Stahl, Ph.D., joined Regeneron in 1991 and has served as executive vice president, research and development since January 2015. Thomas DiCioccio, Ph.D., joined Regeneron in 2010 and serves as senior vice president, pharmacometrics. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. Based on 12 salaries posted anonymously by GSK Vice President Human Resources employees in Skelmersdale, England. Regeneron Pharmaceuticals Vice-president average salary is $-, median salary is $- with a salary range from $- to $-. in computer engineering from Columbia University, his MBA from the McDonough School of Business at Georgetown University and his M.D. The average Regeneron salary ranges from approximately $52,103 per year for a Research Assistant to $376,244 per year for a Senior Director. Know Your Worth. Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail You are now leaving Regeneron.com. from Colorado State University. Regeneron Pharmaceuticals Inc H1B Salary 2020 124 records was found, Median Salary is $126250. Since 1994, she has been a professor in the Departments of Pediatrics, Molecular and Human Genetics, and Neurology and Neuroscience at Baylor College of Medicine. Feb 1, 2023 11:58am. About the VP of Engineering Role: We are looking for an experienced VP of Engineering with a strong technical background from a product development company and, ideally, ERP product development Be the first to add REGENERON PHARMACEUTICALS, INC. Vice President of Laboratory responsibilities. Prior to joining J&J, Christina worked in financial and corporate communications for Biogen and at Boehringer Ingelheim in various pharmaceutical sales and communications roles. He has also served as chair and chief executive officer of TRATE Enterprises LLC, a privately held company, since 2013. Were proud to be named a Glassdoor Best Places to Work 2023 in the U.S. He served as president and chief executive officer of Memorial SloanKetteringCancer Center (MSK) from 2010 until September 2022 and continues to oversee the Craig Thompson Lab, which studies cellular metabolism and its role in disease. Regeneron employees rate the overall compensation and benefits package 4.2/5 stars. Well-versed in leave administration The VP you'll be reporting to has a collaborative leadershipof Monday, February 13th. COMPANY SIZE 5,000 to 9,999 employees INDUSTRY Biotechnology/Pharmaceuticals FOUNDED 1988 WEBSITE https://www.regeneron.com/ Similar Jobs Respiratory Therapist - PRN - Ardmore Mercy Ardmore, OK 11 days ago Apply RRT Focus Staff Ardmore, OK 8 days ago Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. How much do Regeneron employees make? and Ph.D. in chemical engineering from the University of Virginia. Dr. DiCioccio earned an B.S. These charts show the average base salary (core compensation), as well as the average total cash compensation for Vice President of Human Resources in companies like REGENERON PHARMACEUTICALS, INC. in the United States. in economics from Rutgers University. Overall Benefits Rating.css-11cfy92{color:#0caa41 !important;}.css-11cfy92{color:#0caa41 !important;}4.1, Matches half of your contribution up to 5% (of gross pay) on 10%. Mr. Yocums broad knowledge and expertise in Good Manufacturing Practices (GMP) and processes have contributed to the successful launch of every Regeneron commercial product. Dr. Brown has been a director of the company since 1991. from the University of Health Science and Pharmacy and his MBA from Lindenwood University. As well as serving as a R&D leader, Dr. Morton also sponsors the Women in Industry, Science & Engineering at Regeneron (WISER) employee resource group. las molestias. All proxy statements are public filings made available to the general public by the SEC. Senior Vice President, Chief Compliance Officer. Dr. Hirshberg completed his undergraduate and medical degrees at the Hebrew University and is board certified in internal medicine, following his residency at the Hadassah Medical center in Jerusalem. Patrice Gilooly joined Regeneron in 1998 and serves as senior vice president, quality assurance and operations. He received his B.S. Mr. Brooks received both a B.S. He received his MBA in health care administration from Wilmington University. She is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, the Royal Society of London and the American Philosophical Society. Ms. Kowal also served as vice president, clinical operations, on the clinical research organization side of the industry at a number of biotech organizations in a variety of clinical research roles early in her career. from University at Albany. He is responsible for protecting Regenerons intellectual property, including by developing and implementing a comprehensive global IP strategy. Ms. Gilooly has held positions of increasing responsibility in validation and quality assurance and operations. All trademarks mentioned are the property of their respective owners. Overall Benefits Rating.css-11cfy92{color:#0caa41 !important;}.css-11cfy92{color:#0caa41 !important;}4.1, Matches half of your contribution up to 5% (of gross pay) on 10%. Dr. Lowy is a licensed physician and has been board certified in internal medicine and infectious diseases. Based on 1 salaries posted anonymously by AstraZeneca Human Resources Vice President employees in Beckton, England. Lynn Macdonald, Ph.D., joined Regeneron in 1999 and serves as senior vice president, research. from National Taiwan University and his Ph.D. from Harvard University. Alessandra Ravetti, J.D., joined Regeneron in 2012 and serves as senior vice president, associate general counsel. Dr. Kyratsous previously worked at the Howard Hughes Medical Institute and was a postdoctoral fellow at New York University. Gonzalo Merino, Ph.D., J.D., joined Regeneron in 2013 and now serves as senior vice president and chief intellectual property counsel. Chairman of the Board; Retired Chairman of the Board and Chief Executive Officer, Merck & Co., Inc. Dr. Vagelos has been chair of the board since January 1995. Prior to that she was chief diversity officer for Dow Jones, including its flagship brand, The Wall Street Journal. Prior to joining Regeneron, Dr. Murphy worked for seven years at Cadus Pharmaceuticals. Mr. Austin earned a B.S. $2.8M. Prior to joining Fisher, Ms. Poon was vice chair, worldwide chair of pharmaceuticals, member of the executive committee and director at Johnson & Johnson. Dr. Sirulnik is a licensed physician, formerly practicing at Dana-Farber Cancer Institute and Brigham and Womens Hospital and was a fellow in hematology/oncology at Mount Sinai Health System. He has been a professor of molecular genetics and internal medicine and the chair of the Department of Molecular Genetics at the University of Texas Southwestern Medical Center at Dallas since 1977. The highest-paying job at Regeneron is a Senior Director with a salary of $376,244 per year. Dr. Yancopoulos joined Dr. Schleifer in 1989 as founding scientist of the company, and together they built and have managed the company since then. During her tenure, Dr. Morton has established cardiovascular, renal and fibrosis research at Regeneron. Prior to Regeneron, Mr. ONeal held roles at Axovant, Amgen and Express Scripts. He received his B.S. Prior to that, she led executive communication and thought leadership for J&Js Chairman & CEO and oversaw communication for J&Js diversity, equity & inclusion programs and heritage platforms. Mr. Calabro leads a team responsible for providing independent and objective assurance and consulting by bringing a systematic, disciplined approach to evaluating and improving the effectiveness of Regenerons risk management, control and governance processes. Based on 1 salaries posted anonymously by PDR Network Vice President Business Development employees in West Point, PA. He previously held roles on the tax teams at Arthur Anderson, Ernst & Young, and Diageo, and he currently serves as secretary and member of the board of trustees at Intensive Therapeutics, a 501c3 non-profit organization that provides therapy services to children with special needs. Before this, Dr. Reinertsen served as the vice president of corporate development at Vertex Pharmaceuticals. From 2008 to 2015, Dr. Herman was one of only three pharmaceutical industry members on the Executive Committee of the Biomarkers Consortium, a program within the Foundation for the National Institutes of Health. Mr. from Columbia University Law School, where he was a Harlan Fisk Stone Scholar, and his Ph.D. from the Integrated Program in Cellular, Molecular and Biophysical Studies at the Columbia University Graduate School of Arts and Sciences, where he received the Richard C. Parker Award for Outstanding and Innovative Research and a minority pre-doctoral fellowship award. in Science from the University of California, Davis. from the United States Air Force Academy and her M.A. Based on 12 salaries posted anonymously by AstraZeneca Vice President Finance employees in Cannock, England. Most recently she was VP, global head of DE&I at Zendesk. Average Regeneron Vice President yearly pay in the United States is approximately $183,000, which is 24% above the national average. He served as chairman of the board from 1990 through 1994. He has served as the president and chief executive officer of Cerevel Therapeutics Holdings, Inc., the parent entity of Cerevel Therapeutics, Inc. since 2019, and as chair of Cerevel Therapeutics Holdings, Inc. since 2018. Before joining Regeneron, Mr. Underwood worked at Fluor Daniel, the Jacobs Engineering Group and Day Laboratories. #GlassdoorBPTW, We are excited to share that for the second year in a row, BioSpace has named us a Best Place to Work. VA. Senior Vice President, Business Development. Prior to joining Regeneron, Ms. Lozner served as chief compliance officer and special counsel at Rafael Holdings, where she was responsible for building a compliance program for a start-up biotechnology company. Prior to Regeneron, Mr. Carreau worked at Novartis (formerly Chiron Corporation). Made up of our founding scientists, industry experts, Nobel Laureates and members of the National Academy of Sciences, we consistently push the boundaries of scientific excellence and discovery. As Executive Vice President, Finance and Chief Financial Officer at REGENERON PHARMACEUTICALS, INC., Robert E. Landry made $8,298,455 in total compensation. VA. Job TitleVice President, Talent and LearningOverviewAccountable for developing and delivering andmember of the Global Talent and OE Leadership TeamAll About You Experience in HR Business City of Virginia Beach - Virginia Beach Anyone wants to share the salary range for VP at the pharma and biotech? 46 Regeneron Pharmaceuticals average salary is $95,435, median salary is $87,381 with a salary range from $41,600 to $373,100. He also previously served within the internal audit teams at Phillip Morris, General Foods and Bowater, Inc. Mr. Calabro received a B.S. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information.